Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
Condition:   Covid19 Intervention:   Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase) Sponsors:   Jon Simmons;   University of South Alabama Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2020 Category: Research Source Type: clinical trials

Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
Condition:   Covid19 Interventions:   Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase);   Drug: 0.9%sodium chloride Sponsors:   Jon Simmons;   University of South Alabama Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2020 Category: Research Source Type: clinical trials